Highly Efficient Two‐Photon Photodynamic Therapy Using Light‐Sheet Excitation
Two‐photon photodynamic therapy (TP‐PDT), which utilizes near‐infrared light to excite photosensitizer via two‐photon excitation (TPE), is a promising modality in the treatment of deeply seated tumors or thick tumors. However, the TPE domain is much smaller than the tumor volume, significantly limit...
Saved in:
Published in | Laser & photonics reviews Vol. 18; no. 11 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley Subscription Services, Inc
01.11.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Two‐photon photodynamic therapy (TP‐PDT), which utilizes near‐infrared light to excite photosensitizer via two‐photon excitation (TPE), is a promising modality in the treatment of deeply seated tumors or thick tumors. However, the TPE domain is much smaller than the tumor volume, significantly limiting the therapeutical outcomes of TP‐PDT. Here, a light‐sheet TPE system is designed and constructed using a cylindrical lens for highly efficient TP‐PDT. The light‐sheet TPE performance is characterized and optimized via theoretical analysis and experimental studies in solution, phantom, and tumor. The optimized excitation system can reach a large TPE domain of 2.6 × 2.7 × 0.09 mm in the tumor, which is not achievable using conventional TPE methods, enabling TPE and subsequently generated reactive oxygen species to cover the whole tumor under line‐scanning. Outstanding TP‐PDT therapeutic performance of 70% tumor growth inhibition rate is achieved under line‐scanned light‐sheet TPE, making the proposed light‐sheet excited TP‐PDT a potential therapeutic tool for future translational research.
A simple light‐sheet two‐photon excitation system using a cylindrical lens for femtosecond laser shaping achieves a significantly expanded two‐photon excitation domain of 2.6 × 2.7 × 0.09 mm. Through simple 1D scanning, the light‐sheet excited two‐photon phtodynamic therapy achieves about 70% tumor growth inhibition rate in vivo. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ISSN: | 1863-8880 1863-8899 |
DOI: | 10.1002/lpor.202400753 |